Not applicableUnknownNCT01123694What this trial is testingXeroderma Pigmentosum Patient ExperiencesWho this might be right forXeroderma Pigmentosum Henry Ford Health System 15
Not applicableLooking for participantsNCT03300830What this trial is testingMolecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman DiseaseWho this might be right forHuman Immunodeficiency VirusCastleman's DiseaseKaposi's Sarcoma+1 more National Cancer Institute (NCI) 280
Testing effectiveness (Phase 2)Study completedNCT02029430What this trial is testingInvestigate ALDOXORUBICIN in HIV-infected Subjects With Kaposi's SarcomaWho this might be right forKaposi's SarcomaHIV PositiveAIDS ImmunityBio, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00002259What this trial is testingPhase II Study of Intravenous Novantrone(R) in the Treatment of AIDS Related Kaposi's SarcomaWho this might be right forSarcoma, KaposiHIV Infections Lederle Laboratories
Early research (Phase 1)Study completedNCT00000987What this trial is testingChemotherapy Plus Azidothymidine in the Treatment of Kaposi's Sarcoma in Patients With AIDSWho this might be right forSarcoma, KaposiHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 36
Early research (Phase 1)Study completedNCT00002153What this trial is testingTopical Use of 4,4'-Dihydroxybenzophenone-2,4-Dinitrophenylhydrazone (A-007) in the Treatment of Advanced Malignancies Including Kaposi's Sarcoma and Lymphoproliferative DisordersWho this might be right forSarcoma, KaposiHIV InfectionsLymphoproliferative Disorders DEKK-TEC, Inc. 25
Testing effectiveness (Phase 2)Study completedNCT00923936What this trial is testingPilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s SarcomaWho this might be right forSarcoma, Kaposi National Cancer Institute (NCI) 16
Testing effectiveness (Phase 2)Study completedNCT00019188What this trial is testingInterleukin-12 in Treating Patients With AIDS-Related Kaposi's SarcomaWho this might be right forEpidemic Kaposi's SarcomaRecurrent Kaposi's Sarcoma National Cancer Institute (NCI)
Not applicableEnrolling By InvitationNCT06330324What this trial is testingReproductive Options in Inherited Skin DiseasesWho this might be right forIchthyosisPalmoplantar KeratosesEpidermolysis Bullosa+7 more Maastricht University Medical Center 650
Not applicableStudy completedNCT03050788What this trial is testingSmartphone Confocal Microscopy for Diagnosing Kaposi's SarcomaWho this might be right forKaposi Sarcoma Massachusetts General Hospital 363
Testing effectiveness (Phase 2)Study completedNCT01067690What this trial is testingTreatment With Indinavir and Chemotherapy for Advanced Classical Kaposi's SarcomaWho this might be right forKaposi's Sarcoma Barbara Ensoli, MD, PhD 25
Early research (Phase 1)Study completedNCT00000954What this trial is testingChemotherapy Plus ddI or ddC in the Treatment of AIDS-Related Kaposi's SarcomaWho this might be right forSarcoma, KaposiHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 72
Testing effectiveness (Phase 2)Study completedNCT00055237What this trial is testingBevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative PatientsWho this might be right forKaposi's SarcomaHIV InfectionsHIV Seronegativity National Cancer Institute (NCI) 19
Early research (Phase 1)Study completedNCT00581815What this trial is testingSpectroscopy With Surface Coils and DecouplingWho this might be right forAdrenal Cortical CancerBrain CancerBreast Cancer+16 more Memorial Sloan Kettering Cancer Center 582
Testing effectiveness (Phase 2)Ended earlyNCT04155190What this trial is testingPatidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCCWho this might be right forRecurrent Basal Cell Carcinoma Sol-Gel Technologies, Ltd. 47
Testing effectiveness (Phase 2)Study completedNCT00001114What this trial is testingThe Safety and Effectiveness of Interferon Alfa-2B Plus Didanosine in Patients With Kaposi's SarcomaWho this might be right forSarcoma, KaposiHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 90
Large-scale testing (Phase 3)Study completedNCT00002319What this trial is testingDOX-SL in the Treatment of AIDS-Related Kaposi's SarcomaWho this might be right forSarcoma, KaposiHIV Infections Sequus Pharmaceuticals
Not applicableStudy completedNCT00001813What this trial is testingExamination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or TrichothiodystrophyWho this might be right forCockayne SyndromeSkin NeoplasmsXeroderma Pigmentosum+2 more National Cancer Institute (NCI) 709
Testing effectiveness (Phase 2)Study completedNCT01057121What this trial is testingLenalidomide in Treating Patients With AIDS-Associated Kaposi's SarcomaWho this might be right forAIDS-Related Kaposi SarcomaRecurrent Kaposi Sarcoma National Cancer Institute (NCI) 38
Large-scale testing (Phase 3)Study completedNCT00002105What this trial is testingRandomized, Comparative Trial of DOX-SL (Stealth Liposomal Doxorubicin Hydrochloride) Versus Bleomycin and Vincristine in the Treatment of AIDS-Related Kaposi's SarcomaWho this might be right forSarcoma, KaposiHIV Infections Sequus Pharmaceuticals 220